The Innovation Act (HR 3309) Cure is Worse than the Disease House Staff Briefing Washington, DC...

17
The Innovation Act (HR 3309) Cure is Worse than the Disease House Staff Briefing Washington, DC 12/3/13 by Gary Lauder Managing Director of Lauder Partners 1

Transcript of The Innovation Act (HR 3309) Cure is Worse than the Disease House Staff Briefing Washington, DC...

Page 1: The Innovation Act (HR 3309) Cure is Worse than the Disease House Staff Briefing Washington, DC 12/3/13 by Gary Lauder Managing Director of Lauder Partners.

The Innovation Act (HR 3309)Cure is Worse than the Disease

House Staff BriefingWashington, DC 12/3/13

by Gary LauderManaging Director of Lauder Partners

1

Page 2: The Innovation Act (HR 3309) Cure is Worse than the Disease House Staff Briefing Washington, DC 12/3/13 by Gary Lauder Managing Director of Lauder Partners.

Intro

• My name is Gary Lauder & I’m a venture capitalist (Lauder Partners LLC)– Have invested over $500M in VC over past 28 yrs.• In > 80 companies and > 60 VC funds

– Not a lawyer– Co-inventor on a dozen patents– Have no interest in any PAE nor entity behaving as

such

2

Page 3: The Innovation Act (HR 3309) Cure is Worse than the Disease House Staff Briefing Washington, DC 12/3/13 by Gary Lauder Managing Director of Lauder Partners.

My Expertise

• How VC’s consider what to invest in– The role that patents play in that

• How patents affect the success of small co’s.• Patents don’t matter much to SW & internet

companies, but they do to most others• NVCA board has SW/internet types who don’t

like patents, so NVCA has decided to be mild in its criticism of HR 3309

Page 4: The Innovation Act (HR 3309) Cure is Worse than the Disease House Staff Briefing Washington, DC 12/3/13 by Gary Lauder Managing Director of Lauder Partners.

I’m no fan of PAE’s

• I’m Chairman of 2 companies• W/in past 7 mo., both have been challenged• Now fighting in court• Despite experience, HR 3309 more harmful

than helpful.• Would make start-ups THAT NEED PATENTS

harder to fund because harder to succeed• Much of PAE activity is just/fair…

Page 5: The Innovation Act (HR 3309) Cure is Worse than the Disease House Staff Briefing Washington, DC 12/3/13 by Gary Lauder Managing Director of Lauder Partners.

Example of Just PAE

• In 1994, invested in Hybrid Networks, inventor of asymmetrical cable modems

• Cable industry created DOCSIS cable modem standard incorporating some of their tech.

• Company moved to wireless modems, but company ultimately failed

• Now all cable modems are asymmetrical • Assets of company went to debtors

Page 6: The Innovation Act (HR 3309) Cure is Worse than the Disease House Staff Briefing Washington, DC 12/3/13 by Gary Lauder Managing Director of Lauder Partners.

Hybrid saga

• Debtors sold IP to PAE who sued a large MSO• MSO offered $40M to settle, but PAE declined• Went to trial in East Texas and PAE lost• Result: thieves won• Note: I had no interest in the outcome• Retrospective on this is illuminating

Page 7: The Innovation Act (HR 3309) Cure is Worse than the Disease House Staff Briefing Washington, DC 12/3/13 by Gary Lauder Managing Director of Lauder Partners.

Analysis of Hybrid

• I knew that this would be a huge market and there was risk of theft, but induced to invest based on faith in patents as backstop– So did Accel and Sequoia

• Lenders lent company money based on them• For those patents to have had full value,

needed to be salable to a 3rd party (PAE).• If “practicing” was necessary, could have

continued to make a few modems

Page 8: The Innovation Act (HR 3309) Cure is Worse than the Disease House Staff Briefing Washington, DC 12/3/13 by Gary Lauder Managing Director of Lauder Partners.

Fairness

• The cable industry’s cable modem cash flow is about $30B/year

• If the PAE had won, and if the entire industry paid $200M, cable industry still would have still been big winner

• Company was forced from practicing to non due to theft

• I would not have made that investment if the patent regime had been AIA + HR 3309

Page 9: The Innovation Act (HR 3309) Cure is Worse than the Disease House Staff Briefing Washington, DC 12/3/13 by Gary Lauder Managing Director of Lauder Partners.

Litigation is the wrong measure

“Not everything that counts can be counted, and not everything that can be counted counts.” —Albert Einstein•What’s most important about patent system is inducing the right behavior w/o litigation– Entrepreneurs and investors to take risk– Incumbents to buy innovator and not copy

“When people are free to do as they please, they usually imitate each other.” —Eric Hoffer

Page 10: The Innovation Act (HR 3309) Cure is Worse than the Disease House Staff Briefing Washington, DC 12/3/13 by Gary Lauder Managing Director of Lauder Partners.

Conclusion/Epitaph• This bill will be yet another nail in the coffin of

start-up ecosystem & VC in America– Capital inflows to VC are at pre-1998 levels

• More than 10% of our GDP comes from VC-backed companies

• If enacted, together w/the AIA, will take 20 years for effects to play out

• By then you are likely to have been in the hospital room of a loved one wishing that someone had invented the cure s/he needs.

Page 11: The Innovation Act (HR 3309) Cure is Worse than the Disease House Staff Briefing Washington, DC 12/3/13 by Gary Lauder Managing Director of Lauder Partners.

Recommendation

• Don’t succumb to the “troll boogyman” urges towards knee-jerk legislation

• Encourage your colleagues to seek out opposing perspectives from experts such as the ones shared in this briefing

• Thank you for doing so yourselves

Page 12: The Innovation Act (HR 3309) Cure is Worse than the Disease House Staff Briefing Washington, DC 12/3/13 by Gary Lauder Managing Director of Lauder Partners.

Thank you for your attention

Gary LauderLauder Partners

[email protected](650) 323-5700

http://www.lauderpartners.com/PatentReform/

12

Page 13: The Innovation Act (HR 3309) Cure is Worse than the Disease House Staff Briefing Washington, DC 12/3/13 by Gary Lauder Managing Director of Lauder Partners.
Page 14: The Innovation Act (HR 3309) Cure is Worse than the Disease House Staff Briefing Washington, DC 12/3/13 by Gary Lauder Managing Director of Lauder Partners.

Jobs

• Kauffman Foundation study found that all net new US jobs came from startups

• Large companies are net jobs EXPORTERS• Jobs are always important, but more so now• Startups are harmed by this bill• Therefore it will have an adverse jobs impact

Page 15: The Innovation Act (HR 3309) Cure is Worse than the Disease House Staff Briefing Washington, DC 12/3/13 by Gary Lauder Managing Director of Lauder Partners.

PAE recent suit growth due to AIA

• Ironic and not understood• Elimination of joinder is one factor. • Also, the AIA forced patentees to sue < 3 months after patent

issue. The new statute under the AIA at §325(b) provides that if a patentee files suit for infringement within 3 months of the patent issuance, the court may not stay a motion for preliminary injunction on the basis that PGR (or TPCB) petition was filed or instituted to be immune from post-grant. This factor is glossed over by all who recognize that the AIA has a role in the uptick of litigation after the AIA.

Page 16: The Innovation Act (HR 3309) Cure is Worse than the Disease House Staff Briefing Washington, DC 12/3/13 by Gary Lauder Managing Director of Lauder Partners.

Attempts to fix problems from AIA will make it worse

“Most problems begin as solutions.”—Eric Severide

•If one can’t come up w/a perfectly just patent system, then to whom should injustice be allocated?•My answer is away from that precious thing we have in America: the start-up ecosystem•In other countries, private sectors don’t so government tries…with bad results.

Page 17: The Innovation Act (HR 3309) Cure is Worse than the Disease House Staff Briefing Washington, DC 12/3/13 by Gary Lauder Managing Director of Lauder Partners.

Wrong way to make sausage• 1952 Patent Act: written by 2 experts over 4 yrs– Patent judge Giles Rich– Pasquale Federico, chief patent examiner of USPTO– No vested interests or conflicts– Passed both houses w/o debate– Simple and clear, let to huge success

• 2011 America Invents Act written by lobbyists and staffers (non-experts)– Long, complicated & ambiguous– Excluded the interests of start-ups– Innovation Act (HR. 3309) is more of that